IMSUT International Joint Research Project FY2022 – Call for Proposals

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire within your unit

Memorial Deadline: Monday 6th, December 2021

External Deadline: Monday 13th, December 2021


The Institute of Medical Sciences, the University of Tokyo (IMSUT) has been promoting the Joint Usage/Research Center Project since FY2010, supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT). On 13 November 2018, IMSUT was authorized as the “International Joint Research Center for Promoting Basic and Applied Research and Implementing Translational Research,” allowing us to expand our activities worldwide.

In FY 2021, IMSUT was approved to continue its International Joint Research Center project in line with MEXT’s policy. The primary objective of this project is to establish IMSUT as a hub for international joint research to promote and accelerate collaboration between researchers in Japan and abroad. Toward this goal, we have been making efforts to improve the system.

We aim to improve medical science research standards at the international level, to increase new academic and scientific knowledge in medical science, to promote research and development of innovative medicines and medical technology, and to foster medical researchers and promote their wider exchange.

In addition, we are working toward the creation of new interdisciplinary research areas by opening up our research infrastructures and technologies, such as the latest results of genome analysis and regenerative medical technology, to all researchers both in Japan and abroad.

We invite proposals for international joint research in the following three joint research areas: (1) Development of Cutting Edge Medical Therapies, (2) Genome/Cancer/Disease Systems Biology, (3) Infectious Diseases and Immunology.

Additional information can be found here.

Funding Sources

Institure of Medical Science/University of Tokyo

This opportunity was posted by: RGCS

Last modified: November 4, 2021